ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Yonghong Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2609-7720; OpenAlex author ID A5102859491; NIH RePORTER profile ID 14758625. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper · 2026: 1 grant

Papers 1

Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model. Co-author DOI 10.1158/2159-8290.cd-24-0489 ↗

Grants 1

Deciphering the Role of Tumor Suppressor Gene Deficiencies in Modulating PDAC Response to Oncogenic KRAS Inhibition and Immunotherapy K99CA312836 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jincheng Han · 1 shared paper, 2025 · strength 0.25
- Paper Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model. DOI 10.1158/2159-8290.cd-24-0489 ↗
Ronald Anthony Depinho · 1 shared paper, 2025 · strength 0.25
- Paper Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model. DOI 10.1158/2159-8290.cd-24-0489 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.